Congruence Therapeutics Announces Poster Presentation on Discovery of Novel GCase Correctors for Parkinson’s Disease with GBA1 mutations at the 2024 International Congress of Parkinson’s Disease and Movement Disorders Meeting
https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-participation-in-barclays-biotech-1x1-private-company-symposium-302212895.html?tc=eml_cleartime